Volume 6, Issue 5, September 2017, Page: 68-73
Evaluation of Erectile Function and Quality of Life in Patients Undergoing Methadone Maintenance Treatment
Sava Petrov, Second Department of Internal Disease, Section of Endocrinology and Metabolic Diseases, Medical University, Plovdiv, Bulgaria
Maria Orbetzova, Second Department of Internal Disease, Section of Endocrinology and Metabolic Diseases, Medical University, Plovdiv, Bulgaria
Yanko Iliev, Department of Clinical Toxicology, Medical University, Plovdiv, Bulgaria
Doychin Boyadzhiev, University of Plovdiv, Plovdiv, Bulgaria
Lyuba Hadzhiyska, Private Psychiatric Practice Philippopolis Ltd., Plovdiv, Bulgaria
Stefan Popov, Department of Psychiatry, Medical University, Plovdiv, Bulgaria
Received: Jan. 26, 2017;       Accepted: Feb. 10, 2017;       Published: Oct. 18, 2017
DOI: 10.11648/j.sjcm.20170605.11      View  1763      Downloads  58
Abstract
The controversial data for erectile function and quality of life of patients undergoing methadone maintenance treatment (MMT) and lack of questionnaire-based studies, providing information about these bio-psycho-social issues, in Bulgaria motivated the investigators to examine the frequency of erectile dysfunction among patients on methadone maintenance treatment, and to identify quality of life among these subjects. For these needs cross-sectional, observational with no intervention, case-control, questionnaire-based study was performed which included participants from 18 to 40 years of age undergoing MMT for at least six months and clinically healthy people. A total of 91 patients from 5 clinical programs for MMT in Bulgaria took part in the study and 27 clinically healthy people from the same age and without a history of drug abuse, psychiatric and somatic diseases which served as a control group. All participants signed informed consent. For evaluating erectile function International Index of Erectile Function survey was used. SF 36 v.2 quality of life survey was used for assessing the quality of the participants. When comparing results of the quality of life survey in Patient and Control group significant differences were found in all of the components of the survey (p<0.05) with lower results in the Patient group. When analysing results from the IIEF survey significantly lower total scores were present for all components of the survey in the patient as compared to the group of healthy men (p<0.05).
Keywords
Erectile Function, Methadone, IIEF, Erectile Dysfunction, Quality of Life, SF 36
To cite this article
Sava Petrov, Maria Orbetzova, Yanko Iliev, Doychin Boyadzhiev, Lyuba Hadzhiyska, Stefan Popov, Evaluation of Erectile Function and Quality of Life in Patients Undergoing Methadone Maintenance Treatment, Science Journal of Clinical Medicine. Vol. 6, No. 5, 2017, pp. 68-73. doi: 10.11648/j.sjcm.20170605.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Nutt, D.; King, L. A.; Saulsbury, W.; Blakemore, C. "Development of a rational scale to assess the harm of drugs of potential misuse". The Lancet 2007; 369 (9566): 1047–1053.
[2]
GBD 2013 Mortality and Causes of Death, Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013." Lancet 2014; 385: 117–171.
[3]
Vemter A, Buning E: Information for policymakers on the effectiveness of substitution treatment for opiate dependence. Euro Methwork 2003.
[4]
Jamieson BLA, Inc. Literature Review: Methadone Maintenance Treatment. The Office of Canada’s Drug Strategy, Health Canada 2002.
[5]
Национална програма за развитие на лечебна система от метадонови поддържащи програми в Р. България. available at: http://www.ncn-bg.org/.
[6]
Herman J., Sharon S., John L.: Methadone Maintenance Treatment (MMT): A Review of Historical and Clinical Issues. Mt Sinai J Med 2000. Oct-Nov; 67 (5-6): 347-64.
[7]
Bang-Ping J: Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med 2009; 6: 1072–1080.
[8]
Venkatesh K, Mattoo SK, Grover S: Sexual dysfunction in men seeking treatment for opioid dependence: a study from India. J Sex Med 2014; 11: 2055–2064.
[9]
Quaglio G, Lugoboni F, Pattaro C. Erectile dysfunction in male heroin users receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend 2008; 94: 12–8.
[10]
Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 2008; 5: 684–92.
[11]
Brown R, Balousek S, Mandt M, Fleming M. Methadone maintenance and male sexual dysfunction. J Addict Dis 2005; 24: 91–106.
[12]
Zhang M, Zhang H, Shi CX, McGoogan JM, Zhang B, Zhao, L, Zhang M, Rou K, Wu Z: Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China. PLoS One 2014; 9 (2): e88289.
[13]
Amiri M, Khosravi A, Chaman R. Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009. J Res Health Sci. 2010; 10 (2): 104–9.
[14]
Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, et al. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst. Use Misuse. 2005; 40 (12): 1765–76.
[15]
Maremmani I, Pani PP, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine mainte¬nance-treated and methadone maintenance-treated heroin-ad¬dicted patients. J Subst Abuse Treat. 2007; 33 (1): 91–8.
[16]
Wang PW, Lin HC et all. Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study. Harm Reduct J. 2015; 12: 13.
[17]
Chang, K.-C., & Lin, C.-Y. Effects of publicly-funded and quality of life on attendance rate among methadone maintenance treatment patients in Taiwan: an 18-month follow-up study. Harm Reduction Journal. 2015; 12, 40.
[18]
Rosen RC, Riley A, et all. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun; 49 (6): 822-30.
[19]
Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology. 2000; 56: 477-481.
[20]
John E. Ware. SF-36 Health Survey Update SPINE Volume 25, Number 24, 200 pp 3130–3139.
[21]
Ware J. Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 51 (11): 903-912.
[22]
Su, C.-T., Ng, H.-S., Yang, A.-L., & Lin, C.-Y. Psychometric evaluation of the Short Form 36 Health Survey (SF-36) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) for patients with schizophrenia. Psychological Assessment, 2014 26 (3), 980-989.
[23]
Available at https://www.pfizerpatientreportedoutcomes.com/ and http://www.qualitymetric.com/Portals/0/Uploads/Documents/Public/QM_Catalog_2011.pdf.
[24]
Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse. 2003; 29 (2): 323–35.
[25]
Ryan, CF, & White, JM. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction. 1996; 91, 39–45.
[26]
Maremmani I, Pani PP, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine mainte¬nance-treated and methadone maintenance-treated heroin-ad¬dicted patients. J Subst Abuse Treat. 2007; 33 (1): 91–8. doi: 10.1016/j. jsat.2006.11.009.
[27]
Rudolf, H., & Watts, J. Quality of life in substance abuse and dependency. International Review of Psychiatry. 2002; 14, 190–197.
[28]
Sun, HM, Li, XY, Chow, EP, Li, T, Xian, Y, Lu, YH, Zhang, L. Methadone maintenance treatment programme reduces criminal activity and improves social wellbeing of drug users in China: A systematic review and meta-analysis. BMJ Open. 2015; 5, e005997.
[29]
Teoh Bing Fei J, Yee A, Habil MH. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life. Am J Addict 2016 Jan; 25 (1): 49-55.
[30]
Nordmann S, Lions C, Vilotitch A et all. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study). Psychopharmacology (Berl). 2016Apr; 233 (7).
[31]
Alshomrani AT. Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia. Saudi Med J. 2015Jul; 36 (7): 802-6.
[32]
Hallinan R, Byrne A, AghoK, McMahonC, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 20085: 684–692.
[33]
de la Rosa RE, Hennessey JV. Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone. Endocr Pract 19962: 4–7.
[34]
Cicero TJ. Opiate and opioid modulation of reproductive endocrinology in the male and female: development and pregestational aspects. NIDA Res Monogr 1984 55: 14–23.
[35]
Gerra G et all. Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates. Eur Addict Res. 2016; 22 (3): 163-75.
[36]
Yee A et. all. Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment. PLoS One. 2016 Jan 28; 11 (1): e0147852.
Browse journals by subject